Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Jan 16;19(1):16.
doi: 10.1186/s12890-019-0780-3.

Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients

Claudia Ravaglia  1 , Athol U Wells  2 , Sara Tomassetti  3 , Carlo Gurioli  3 , Christian Gurioli  3 , Alessandra Dubini  4 , Alberto Cavazza  5 , Thomas V Colby  6 , Sara Piciucchi  7 , Silvia Puglisi  3 , Marcello Bosi  3 , Venerino Poletti  3   8
Affiliations
Observational Study

Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients

Claudia Ravaglia et al. BMC Pulm Med. .

Abstract

Background: Standardization of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases is imminent; however, the majority of published series on cryobiopsy include a limited number of patients and are characterized by several differences in procedural technical details.

Methods: This is an observational, retrospective cohort study. Aim of the study was to suggest some sampling strategies related to transbronchial cryobiopsy in the diagnostic work-up of patients with diffuse parenchymal lung diseases.

Results: Six hundred ninety-nine patients with suspected diffuse parenchymal lung disease were recruited. A specific pathological diagnosis was achieved in 614/699 cases (87.8%) and a multidisciplinary diagnosis was obtained in 630/699 cases (90.1%). Diagnostic yield was significantly influenced by the number of samples taken (1 vs ≥ 2 biopsies, p < 0.005). In 60.4% of patients, biopsies were taken from one site and in 39.6% from different sites (in the same lobe or in two different lobes), with a significant increase in diagnostic yield, specifically in patients with fibrotic lung diseases (65.5% vs 93.4%, p < 0.0001). The 2.4 mm or 1.9 mm probes were used, with no differences in terms of diagnostic yield. Regarding safety, pneumothorax occurred in 19.2% and was influenced by baseline lung function; in all patients Fogarty balloon has been used and severe haemorrhage occurred in 0.7% of cases. Three patients (0.4% of cases) died within 30 days after the procedure.

Conclusions: We propose some sampling strategies of cryobiopsy which seem to be associated with a higher diagnostic yield and a favorable risk/benefit ratio: sampling at least two samples in different sites, using either the 2.4 mm or the 1.9 mm probe, intubating the patients and using bronchial blockers/catheters.

Keywords: Cryobiopsy; DPLDs; Diffuse parenchymal lung disease; ILD; IPF; Idiopathic pulmonary fibrosis; Interstitial lung disease; TLCB; Transbronchial lung cryobiopsy.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study was approved by the Area Vasta Romagna Ethical Committee and conducted in accordance with the amended Declaration of Helsinki; written informed consent has been obtained from all subjects prior to the procedure.

Consent for publication

Not applicable.

Competing interests

VP has served as a paid consultant to Erbe, Germany; none of all others have any potential conflicts of interest with any companies/organizations whose products or services may be discussed in this paper.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Casoni GL, Tomassetti S, Cavazza A, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One. 2014;9:e86716. doi: 10.1371/journal.pone.0086716. - DOI - PMC - PubMed
    1. Ravaglia C, Bonifazi M, Wells AU, et al. Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature. Respiration. 2016;91:215–227. doi: 10.1159/000444089. - DOI - PubMed
    1. Tomassetti S, Wells AU, Costabel U, et al. Bronchoscopic lung Cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2016;193:745–752. doi: 10.1164/rccm.201504-0711OC. - DOI - PubMed
    1. Ravaglia C, Wells AU, Tomassetti S, et al. Transbronchial lung cryobiopsy in diffuse parenchymal lung disease: comparison between biopsy from 1 segment and biopsy from 2 segments - diagnostic yield and complications. Respiration. 2017;93:285–292. doi: 10.1159/000456671. - DOI - PubMed
    1. Iftikhar IH, Alghothani L, Sardi A, et al. Transbronchial lung cryobiopsy and video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse parenchymal lung disease: a meta-analysis of diagnostic test accuracy. Ann Am Thorac Soc. 2017;14:1197–1211. - PubMed

Publication types